相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Precision Medicine Approaches to Prevent Gastric Cancer
Juntaro Matsuzaki et al.
GUT AND LIVER (2021)
TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody
Megan Minnix et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer
Zengbao Lin et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
Yilin Tong et al.
BMC CANCER (2021)
Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer
William M. Grady et al.
GASTROENTEROLOGY (2021)
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
Runzhe Shu et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer
Liang Guo et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2021)
Association of preoperative and postoperative CA72-4 with gastric cancer outcome
Ting Wu et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
Yunjin Yao et al.
FRONTIERS IN GENETICS (2021)
Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies
Lornella Seeneevassen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Highly Sensitive and Cost-Effective Portable Sensor for Early Gastric Carcinoma Diagnosis
Saw-Lin Oo et al.
SENSORS (2021)
Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
Wei Xu et al.
FRONTIERS IN ONCOLOGY (2021)
Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment
Zining Liu et al.
BMC GASTROENTEROLOGY (2021)
Circulating tumor cells: A surrogate to predict the effect of treatment and overall survival in gastric adenocarcinoma
Yinxing Zhu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2021)
Diagnostic value of macrophage inhibitory cytokine 1 as a novel prognostic biomarkers for early gastric cancer screening
Xin Ge et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Current immunoassay methods and their applications to clinically used biomarkers of breast cancer
Seri Jeong et al.
CLINICAL BIOCHEMISTRY (2020)
Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer
Xuyang Gong et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis
Alexander Charles Ford et al.
GUT (2020)
Comparison of ELISA with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination
Jessica S. Bolton et al.
MALARIA JOURNAL (2020)
Evaluation of the value of multiparameter combined analysis of serum markers in the early diagnosis of gastric cancer
Zhi-Guo Zhang et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
A radiomics-based model for prediction of lymph node metastasis in gastric cancer
Xujie Gao et al.
EUROPEAN JOURNAL OF RADIOLOGY (2020)
Electrochemical immunosensor based on binary nanoparticles decorated rGO-TEPA as magnetic capture and Au@PtNPs as probe for CEA detection
Liangli Cao et al.
MICROCHIMICA ACTA (2020)
Artificial intelligence in gastric cancer: Application and future perspectives
Peng-Hui Niu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Non-Invasive Early Molecular Detection of Gastric Cancers
Hiroyuki Yamamoto et al.
CANCERS (2020)
Correlation between tumor marker CA72-4 and prognosis of patients with gastric cancer A protocol for systematic review and meta-analysis
Minxia Li et al.
MEDICINE (2020)
Evaluation of an Element-Tagged Duplex Immunoassay Coupled with Inductively Coupled Plasma Mass Spectrometry Detection: A Further Study for the Application of the New Assay in Clinical Laboratory
Wencan Jiang et al.
MOLECULES (2020)
Prognostic value of CEA/CA72-4 immunohistochemistry in combination with cytology for detecting tumor cells in peritoneal lavage in gastric cancer
Linlin Qu et al.
JOURNAL OF CANCER (2020)
Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients
Li Li et al.
YONSEI MEDICAL JOURNAL (2020)
Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer
Muhammad Abbas et al.
CURRENT PROBLEMS IN CANCER (2019)
Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer
Jiejie Qin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1
Jingjing Yang et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2019)
Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine
Giovanna Rossi et al.
CANCER RESEARCH (2019)
Recent advances in gastric cancer early diagnosis
Laura Necula et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis
Hong Jiang et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Spatial distribution characteristics of tumor marker CA724 reference values in China
Jing Jing et al.
CANCER MEDICINE (2019)
Circular RNA hsa_circ_0006848 Related to Ribosomal Protein L6 Acts as a Novel Biomarker for Early Gastric Cancer
Jun Lu et al.
DISEASE MARKERS (2019)
Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
Chao Huang et al.
FRONTIERS IN ONCOLOGY (2019)
The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma
Junhun Cho et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
Wei Peng et al.
SCIENTIFIC REPORTS (2019)
An abnormal elevation of serum CA72-4 rather than other tumor markers can be caused by use of colchicine
Bing Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2019)
A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4)
Jing Guo et al.
ONCOTARGET (2018)
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
Oliver A. Zill et al.
CLINICAL CANCER RESEARCH (2018)
Prevalence and causes of abnormal PSA recovery
Noemie Lautenbach et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer
Rui Zhao et al.
MOLECULAR CANCER (2018)
Biomarkers of gastric cancer: Current topics and future perspective
Tasuku Matsuoka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Multiple cytokine profiling in serum for early detection of gastric cancer
Jian Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells
Ting-Ting Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
The Combination of Seven Preoperative Markers for Predicting Patients with Gastric Cancer to Be Either Stage IV or Non-Stage IV
Wei Ge et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
Raffaella Rossin et al.
NATURE COMMUNICATIONS (2018)
Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology
Magdalena Cisło et al.
Oncotarget (2018)
Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients
Shufang Ning et al.
JOURNAL OF CANCER (2018)
Gastric cancer: epidemiology, prevention, classification, and treatment
Robert Sitarz et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity
Qing Pan et al.
PLOS ONE (2018)
Association of HER2 gene amplification and tumor progression in early gastric cancer
Kazuki Kanayama et al.
VIRCHOWS ARCHIV (2018)
Diagnostic role of carbohydrate antigen 72-4 for gastrointestinal malignancy screening in Chinese patients: A prospective study
Shu Ling Wang et al.
JOURNAL OF DIGESTIVE DISEASES (2018)
An Alternative Method for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4
Junxiu Yu et al.
JOURNAL OF GASTROINTESTINAL CANCER (2018)
Prognostic Tools in Patients With Advanced Cancer: A Systematic Review
Claribel P. L. Simmons et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2017)
Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer
Yvette N. Lamb et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Population screening and treatment of Helicobacter pylori infection
Anthony O'Connor et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients
Lu Bai et al.
ONCOLOGY REPORTS (2017)
Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
Carl A. K. Borrebaeck
NATURE REVIEWS CANCER (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer
Ying-qiu Pan et al.
HUMAN IMMUNOLOGY (2016)
Nationwide Multicenter Reference Interval Study for 28 Common Biochemical Analytes in China
Liangyu Xia et al.
MEDICINE (2016)
CdSe/ZnS Quantum Dot-Labeled Lateral Flow Strips for Rapid and Quantitative Detection of Gastric Cancer Carbohydrate Antigen 72-4
Xinyu Yan et al.
NANOSCALE RESEARCH LETTERS (2016)
Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study
Xin-Zu Chen et al.
ONCOTARGET (2016)
CdSe/ZnS Quantum Dot-Labeled Lateral Flow Strips for Rapid and Quantitative Detection of Gastric Cancer Carbohydrate Antigen 72-4
Xinyu Yan et al.
NANOSCALE RESEARCH LETTERS (2016)
Ultrasensitive electrochemical immunosensor for carbohydrate antigen 72-4 based on dual signal amplification strategy of nanoporous gold and polyaniline-Au asymmetric multicomponent nanoparticles
Haixia Fan et al.
BIOSENSORS & BIOELECTRONICS (2015)
Sandwich-type electrochemical immunosensor using dumbbell-like nanoparticles for the determination of gastric cancer biomarker CA72-4
Dan Wu et al.
TALANTA (2015)
Prognostic significance of tumour markers in Chinese patients with gastric cancer
Xiaowen Liu et al.
ANZ JOURNAL OF SURGERY (2014)
CA72-4 combined with CEA, CA125 and CA19-9 improves the sensitivity for the early diagnosis of gastric cancer
Ai-Ping Yang et al.
CLINICA CHIMICA ACTA (2014)
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association
Hideaki Shimada et al.
GASTRIC CANCER (2014)
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
Francois-Clement Bidard et al.
LANCET ONCOLOGY (2014)
Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer
Qing Wang et al.
MEDICAL ONCOLOGY (2014)
Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents
Hark Kyun Kim et al.
PHARMACOGENOMICS (2014)
Liquid biopsy of gastric cancer patients: Circulating tumor cells and cell-free nucleic acids
Masahiro Tsujiura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
Zhipeng Sun et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment
Fangxuan Li et al.
BIOMARKERS (2013)
Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination
Shigenobu Emoto et al.
GASTRIC CANCER (2012)
Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population
Xin-Zu Chen et al.
MOLECULAR BIOLOGY REPORTS (2012)
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
John R. Prensner et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Reference values of thirty-one frequently used laboratory markers for 75-year-old males and females
Ingvar Ryden et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus-Related Hepatocellular Carcinoma
Jian Zhou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Relationships Between Perioperative CEA, CA 19-9, and CA 72-4 and Recurrence in Gastric Cancer Patients After Curative Radical Gastrectomy
Dae Hoon Kim et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Improved Efficacy of α-Particle-Targeted Radiation Therapy
Diane E. Milenic et al.
CANCER (2010)
Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays
Fabio Gasparri et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2009)
Prognostic Value of Preoperative CEA, CA 19-9, CA 72-4, and AFP Levels in Gastric Cancer
Edip Ucar et al.
ADVANCES IN THERAPY (2008)
Development of time-resolved immunofluorometric assays for CA 72-4 and application in sera of patients with gastric tumors
Shi Le Sheng et al.
CLINICA CHIMICA ACTA (2007)
Clinical outcomes with Laparoscopic stage M1, unresected gastric adenocarcinoma
AI Sarela et al.
ANNALS OF SURGERY (2006)
Preoperauve hCGβ and CA 72-4 are prognostic factors in gastric cancer
J Louhimo et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma
MJ Gaspar et al.
TUMOR BIOLOGY (2001)
Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer
D Marrelli et al.
AMERICAN JOURNAL OF SURGERY (2001)
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer
M Ychou et al.
DISEASE MARKERS (2000)
分享论文
